Biogen Inc. (BIIB) financial statements (2020 and earlier)

Company profile

Business Address 225 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,4371,2253,6894,8953,4291,8451,223
Cash and cash equivalents2,3441,2251,5742,3271,3081,205603
Short-term investments2,094 2,1152,5692,121640620
Receivables1,9341,9591,7871,4421,2271,292824
Inventory, net of allowances, customer advances and progress billings7529309031,002893804659
Inventory7529309031,002893804659
Prepaid expense 271     
Other current assets7436889621,093837447226
Other undisclosed current assets5822,569533301315283253
Total current assets:8,4487,6417,8738,7326,7004,6733,185
Noncurrent Assets
Inventory, Noncurrent 7     
Operating lease, right-of-use asset422
Property, plant and equipment3,1383,6013,1822,5022,1881,7661,751
Long-term investments and receivables1,814 3,0572,8292,7601,471626
Long-term investments1,814 3,0572,8292,7601,471626
Intangible assets, net (including goodwill)9,1398,8268,5127,4786,7495,7895,708
Goodwill5,7465,7064,6333,6692,6641,7601,233
Intangible assets, net (excluding goodwill)3,3923,1203,8803,8084,0854,0294,475
Other noncurrent assets1,2391,6911,0281,3361,108619594
Deferred tax assets, net2,154     
Other undisclosed noncurrent assets3,2851,369     
Total noncurrent assets:19,03617,64815,77914,14512,8059,6448,678
TOTAL ASSETS:27,48425,28923,65322,87719,50514,31711,863
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5084344645124761,420743
Accounts payable382371396280267229220
Accrued liabilities     629 
Employee-related liabilities     394343
Taxes payable1266468232209168180
Debt1,495 35533
Liability for uncertainty in income taxes     8099
Business combination, contingent consideration, liability     266
Deferred revenue and credits   121173
Other liabilities2,4292,8612,9012,9042,0971,8191,355
Other undisclosed current liabilities     (1,490)(616)
Total current liabilities:4,4323,2953,3683,4202,5782,2201,758
Noncurrent Liabilities
Long-term debt and lease obligation, including:411  1618563568
Long-term debt, excluding current maturities   6,5566,560563568
Operating lease, liability411
Other undisclosed long-term debt and lease obligation   (6,540)(6,542)  
Liabilities, other than long-term debt2,3693,0261,7518161,0311,150892
Accounts payable and accrued liabilities802    249 
Deferred tax liabilities, net1,6361239312551233
Other liabilities1,3711,3891,629723906650659
Business combination, contingent consideration, liability196    200
Other undisclosed noncurrent liabilities6,2815,9375,9356,4966,503(430)25
Total noncurrent liabilities:9,0608,9627,6867,3287,5521,2831,484
Total liabilities:13,49212,25711,05510,74810,1303,5033,242
Stockholders' equity
Stockholders' equity attributable to parent13,99613,04012,61312,1409,37310,8098,620
Common stock0000000
Treasury stock, value(2,977)(2,977)(2,977)(2,612)(2,612)(2,612)(1,725)
Additional paid in capital  98  4,1964,024
Accumulated other comprehensive loss(92)(240)(318)(320)(224)(59)(28)
Retained earnings17,06516,25715,81015,07212,2089,2846,349
Stockholders' equity attributable to noncontrolling interest(4)(8)(15)(12)251
Total stockholders' equity:13,99213,03212,59812,1299,37510,8148,621
TOTAL LIABILITIES AND EQUITY:27,48425,28923,65322,87719,50514,31711,863

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues14,23313,45312,27411,44910,7649,7036,932
Revenue, net10,71510,1349,4258,5085,806
Cost of revenue(2,995)(2,736)(1,805)(1,527)(1,282)(1,222)(943)
Cost of goods and services sold(1,997)(1,816)(1,707)(1,527)(1,282)(1,222)(905)
Other undisclosed gross profit92092017548425185
Gross profit:12,15811,63710,6449,9709,5238,5326,075
Operating expenses(4,530)(4,828)(5,125)(4,795)(4,602)(4,666)(3,499)
Other undisclosed operating income (loss)(920)(920)(175)(25)(31)107(60)
Operating income:6,7085,8895,3445,1504,8913,9722,516
Nonoperating income (expense)10411(215)(217)(124)(24)(42)
Investment income, nonoperating12211379  138
Foreign currency transaction gain (loss), before tax(1)(10)6  (12)(15)
Other nonoperating expense(13)(11)(13)(217)(124)(26)(35)
Interest and debt expense(191)(201)(251)(260)(96)(30)(32)
Other undisclosed income from continuing operations before equity method investments, income taxes191201251260962839
Income from continuing operations before equity method investments, income taxes:6,8125,9005,1294,9334,7673,9472,481
Loss from equity method investments(67)   (13)(15)(17)
Income from continuing operations before income taxes:6,7455,9005,1294,9334,7553,9322,463
Income tax expense(1,352)(1,426)(2,459)(1,237)(1,162)(990)(601)
Net income:5,3944,4742,6703,6963,5932,9421,862
Net income (loss) attributable to noncontrolling interest2(43)(131)7(46)(7) 
Net income attributable to parent:5,3964,4312,5393,7033,5472,9351,862
Other undisclosed net loss available to common stockholders, basic      (0)
Net income available to common stockholders, diluted:5,3964,4312,5393,7033,5472,9351,862

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:5,3944,4742,6703,6963,5932,9421,862
Other comprehensive income (loss)15576(2)961653228
Other undisclosed comprehensive income (loss)  3(192)(329)(63) 
Comprehensive income:5,5494,5502,6723,6003,4292,9101,890
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(89)(43)131(7)467 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent91 (262)14(92)(14) 
Comprehensive income, net of tax, attributable to parent:5,5524,5072,5413,6073,3832,9031,890

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: